日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs

接受包含新药和老药新用方案治疗的多重耐药结核病患者的妊娠和分娩结局

Lotia Farrukh, Ismat; Lachenal, Nathalie; Adenov, Malik M; Ahmed, Saman; Algozhin, Yerkebulan; Coutisson, Sylvine; Garavito, Epifanio Sánchez; Hewison, Catherine; Holtzman, David; Huerga, Helena; Janmohamed, Aleeza; Khan, Palwasha Y; Jacques, Gamarly Leblanc; Lomtadze, Nino; Melikyan, Nara; Mitnick, Carole D; Mussabekova, Gulnaz; Osso, Elna; Perea, Sara; Putri, Fauziah Asnely; Rashidov, Mahmud; Rich, Michael L; Sakhabutdinova, Yekaterina; Seung, Kwonjune J; Stambekova, Assel; Vásquez, Dante Vargas; Franke, Molly F; Khan, Uzma

Norine: A powerful resource for novel nonribosomal peptide discovery

Norine:发现新型非核糖体肽的强大资源

Pupin, M; Esmaeel, Q; Flissi, A; Dufresne, Y; Jacques, P; Leclère, V

Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3)

白细胞介素 3 和白细胞介素 11 之间的负向串扰由细胞因子信号传导抑制因子 3 (SOCS-3) 介导

F Magrangeas, O Boisteau, S Denis, Y Jacques, S Minvielle

The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells

白细胞介素 (IL)-2 的第一个 α 螺旋折叠为同型四聚体,作为 IL-2 受体 β 链的激动剂,并诱导淋巴因子激活的杀伤细胞

R Eckenberg, T Rose, J L Moreau, R Weil, F Gesbert, S Dubois, D Tello, M Bossus, H Gras, A Tartar, J Bertoglio, S Chouaïb, M Goldberg, Y Jacques, P M Alzari, J Thèze